The FAA penalty follows findings of numerous safety violations, adding regulatory pressure as Boeing works to restore manufacturing quality.

The large combat aircraft award and major commercial aircraft orders are reshaping the investment case for Boeing's defense and commercial units.

The expansion and analyst enthusiasm come as Caterpillar shares hover above $800, with bulls projecting further gains on infrastructure and data center demand.

Strong top-line growth positions GE Aerospace for its upcoming quarterly report, with the engine maker benefiting from sustained aftermarket and defense demand.

Analysts stay constructive on the power equipment maker as its cash outlook strengthens, even as the stock consolidates below price targets.

Deere's post-earnings gain and fair-value assessments come as the company shifts toward construction and smaller equipment alongside its precision agriculture p

Rising factory input costs signal renewed inflationary pressure even as consumer demand holds up.

A dividend increase would extend the medical imaging unit's shareholder return record as it operates independently from GE.

The defense award is being read by retail investors as a catalyst for the broader space sector.

The Ohio investment is being framed as a boost for Bayer and surrounding industrial and health care names.

Honeywell's upcoming report is a key test for the diversified industrial, whose aerospace unit faces a competitive landscape.

The acquisition and ERP fix are central to whether the industrial power transmission maker's valuation holds up.

The acquisition prompts a reassessment of the contract logistics provider's growth trajectory.

A new disclosure refocuses investors on the automation and industrial software company's outlook.

The ballot could lead to industrial action at the Australian carrier's freight operations.

The divestiture trims the conglomerate's industrial equipment footprint in the Caribbean.

RBC's analyst actions span Boston Scientific, Abbott, Zimmer Biomet, Stryker and Intuitive Surgical, signaling broad bullishness on the medtech sector.

The machine vision product launch is being weighed against the company's growth prospects.